The flower is the reproductive unit in angiosperms, and its origin contributed to angiosperm evolution and diversification.[@cit0001] The female reproductive part is called the gynoecium, a highly complex organ with great diversity of forms.[@cit0003] The Arabidopsis gynoecium is a complex structure, which consists of two congenitally fused carpels that arise from the gynoecial primordia at the center of the flower. A key event during gynoecium development is the establishment of the Carpel Margin Meristem (CMM). The CMM is an important meristematic tissue that gives rise to different tissues that are very important for sexual reproduction: the placenta, ovules, septum, transmitting tract, style, and stigma. All these tissues and structures are in the medial domain, and the two carpel walls (or ovary walls) form the lateral domains.[@cit0005]

The phytohormones auxin and cytokinin are key regulators of plant growth and development. The interactions between auxin and cytokinin play a crucial role in several and significant developmental processes such as maintenance of stem-cells, and vascular and root development.[@cit0007] However, it is only recently that we have begun to understand the molecular mechanisms of the interaction between the auxin and cytokinin pathways, which can be antagonistic or synergistic (compared to the yin-yang concept), where their combined activity has a greater effect than just the sum of their separate effects.[@cit0011] Recently, we have proposed a model, in which cytokinin signaling is important during the early steps of CMM and septum development in the gynoecium.[@cit0014] Furthermore, in the medial domain, active cytokinin signaling results in the activation of the auxin biosynthesis gene *TRYPTOPHAN AMINOTRANSFERASE OF ARABIDOPSIS 1* (*TAA1*) and the auxin efflux transporter gene *PIN-FORMED 3* (*PIN3*). In this domain of the ovary of the young gynoecium (CMM and septa primordia), there is no expression of the auxin response *DR5* reporter, suggesting that the produced auxin in the medial domain is redistributed towards the repla and valves (lateral domain) in a PIN-dependent mode.[@cit0014] Most likely, afterwards the auxin is transported to the apical part of the gynoecium, creating an auxin flux resulting upwards growth of the gynoecial tube.[@cit0015] Figure 1.SPT affects the auxin response in the gynoecium. (A-L) Confocal laser scanning microscope (CLSM) imaging of the fluorescence signal of the auxin transcriptional response reporter *DR5rev::GFP* in stage 9 gynoecia of wild type (A-C), *spt-2* (D-F), and *35S::SPT* (G-I). White pointed boxes in (A, D, G) indicate the regions of observation, from the top (B, E, H) or in transverse sections (C, F, I). (J-K) DR5 signal expression in stage 12 gynoecia of wild type (J), *spt-2* (K), and *35S::SPT* (L). GFP signal in green; Propidium iodide (PI) counter stain in purple. Scale bars: 50 µm (J-L), 20 µm (A, D, G; inset in J, L), 10 µm (B, C, E, F, H, I).

Moreover, we identified SPATULA (SPT),[@cit0016] a member of the basic Helix-Loop-Helix (bHLH) transcription factor family, as a positive regulator of cytokinin signaling in the medial region of the ovary.[@cit0014] Our results demonstrate that SPT positively controls the cytokinin signaling output, in part through type-B *ARABIDOPSIS RESPONSE REGULATOR* (*ARR*) gene activation, at least by direct regulation of *ARR1*.[@cit0014] On the other hand, it has been shown that *SPT* modulates auxin signaling during gynoecium and style-stigma development.[@cit0017] These observations raised the question of whether the *SPT* gene could also be involved in the modulation of auxin signaling in the ovary region of the gynoecium. To answer this question, we crossed the auxin response reporter line *DR5rev::GFP*[@cit0019] to the *spt-2* mutant and the *35S::SPT* line to investigate the spatial distribution of auxin signaling in the CMM and septum in these genotypes.

In the wild-type style-stigma region, the DR5 signal is mainly seen as a ring 'around' the style at stage 9, as it has been previously demonstrated[@cit0015] ([Fig. 1A](#f0001){ref-type="fig"}, [B](#f0001){ref-type="fig"}). However, in the ovary region, DR5 signal is mainly confined to presumptive provasculature cells and presumptive ovule primordia ([Fig. 1C](#f0001){ref-type="fig"}),[@cit0014] and no GFP signal was detected in the septum or transmitting tract at stage 12 ([Fig. 1](#f0001){ref-type="fig"}), as reported before.[@cit0014] While DR5 signal is absent in these medial tissues, TCS signal is clearly present there.[@cit0014]

On the other hand, in the *spt* mutant the DR5 signal failed to form this ring-shape expression pattern in the style region but was observed in two separate regions, probably due to the lack of fused tissue ([Fig. 1D](#f0001){ref-type="fig"}, [E](#f0001){ref-type="fig"}), which is consistent with previous analysis.[@cit0017] Interestingly, in the ovary region, DR5 signal was still detected in the presumptive provasculature cells in the *spt* mutant ([Fig. 1](#f0001){ref-type="fig"}). The DR5 signal, however, was not clearly defined and in some occasions, we observed a moderate expansion of its expression ([Fig. 1](#f0001){ref-type="fig"}). In contrast, ectopic *SPT* expression caused a mild reduction in the DR5 fluorescence signal in the provasculature cells of the ovary ([Fig. 1I](#f0001){ref-type="fig"}). Although, in the style-stigma region of *35S::SPT* gynoecia, the DR5 signal is increased ([Fig. 1H](#f0001){ref-type="fig"}, [L](#f0001){ref-type="fig"}). In summary, this data suggests that *SPT* affects the auxin-signaling response during gynoecium development.

Auxin and cytokinin interact in complex ways, either antagonistically or synergistically, depending on the developmental context.[@cit0007] To test whether auxin application can change the cytokinin signaling response, and whether the change requires a functional SPT, we treated inflorescence apices of the cytokinin response reporter *TCS::GFP*[@cit0007] and of *spt-2 TCS::GFP* with the auxin Indole 3-Acetic Acid (IAA). In young gynoecia stages (stage 7--9), TCS signal is absent in the *spt-2* mutant background, because SPT is necessary for cytokinin signaling in the medial domain in the ovary at those stages.[@cit0014] However, from gynoecium stage 10 onwards, a SPT-independent TCS signal can be observed (inset in [Fig. 2E](#f0002){ref-type="fig"}).[@cit0014] In the wild type *TCS::GFP* line, auxin application led to an increase of the TCS signal in the presumptive provasculature cells and septa primordia (as an example, a stage 10 gynoecium is presented in [Fig. 2B](#f0002){ref-type="fig"}). In young *spt* gynoecia, the TCS signal remained absent even when gynoecia are treated with IAA. In untreated stage 10 *spt* gynoecia, TCS signal was detectable in the septum, which coincides with the transmitting tract formation ([Fig. 2C](#f0002){ref-type="fig"}). However, at this stage, the *spt TCS::GFP* auxin-treated gynoecia showed a lack of induction of the TCS signal ([Fig. 2D](#f0002){ref-type="fig"}, [E](#f0002){ref-type="fig"}). The results of these experiments indicate that auxin potentiates the cytokinin response, in a SPT-dependent manner. Moreover, and strikingly, the TCS signal not only could not be induced by auxin in the *spt* mutant background, but even the low signal observed in stage 10 gynoecia completely disappeared. This suggests that SPT is needed to maintain TCS signaling in stage 10--12 gynoecia in the presence of a high auxin concentration. Recently, it has been reported that a high auxin concentration disrupts the protein-protein interaction between the transcription factors ETTIN (ETT/ARF3) and INDEHISCENT (IND), both important for gynoecium development.[@cit0025] So maybe something similar happens with the complex that permits cytokinin signaling (TCS signal) at stage 10--12 gynoecia; the complex, without SPT, would not be stable in the presence of a high auxin concentration. Figure 2.Synergistic relationship between auxin and cytokinin signaling in the gynoecium. (A-E) CLSM imaging of the fluorescence signal of the cytokinin transcriptional response reporter *TCS::GFP* in transverse sections of the ovary, without or with auxin (100 μM IAA for 48 hours) treatment. TCS signal in wild type gynoecia treated for 48 hours with Mock (A) or IAA (B), *spt-2* treated for 48 hours with Mock (C) or IAA (D-E). (E inset) TCS signal in a stage 12 *spt-2* gynoecium of a non-treated plant. (F-I) CLSM imaging of the fluorescence signal of the auxin transcriptional response reporter *DR5rev::GFP* in transverse sections of the ovary, without or with auxin (100 μM IAA for 48 hours) treatment. DR5 signal in wild type stage 10 gynoecia treated for 48 hours with Mock (F) or IAA (G), *spt-2* treated for 48 hours with Mock (H) or IAA (I). (J) DR5 signal in a wild type stage 9 gynoecium treated for 48 hours with cytokinin (100 μM BAP; 6-Benzylaminopurine). GFP signal in green; PI counter stain in purple. Scale bars: 20 µm (E and inset), 10 µm (A-D, F-J).

Next, we evaluated the effects of auxin application on the *DR5* reporter line in the gynoecium. The IAA treatment of wild type plants led to an increase in DR5 signal, mainly in the medial and lateral provasculature cells, as expected ([Fig. 2G](#f0002){ref-type="fig"}). As mentioned above, the DR5 signal in the *spt* mutant background is a little bit less defined, but not too much affected ([Fig. 2H](#f0002){ref-type="fig"}). When these *spt DR5rev::GFP* plants were treated with IAA, the DR5 signal increased ([Fig. 2I](#f0002){ref-type="fig"}), similar as what happened in a wild type background. The results suggest that the auxin signaling response to exogenous auxin in the ovary is not dependent on SPT. This is also in line with previous reports that auxin can complement the apical fusion defects in the style-region of the *spt* gynoecium.[@cit0026]

Several studies indicated the existence of a synergistic effect between auxin and cytokinin signaling in several significant developmental processes.[@cit0011] We recently found that cytokinin signaling promotes auxin biosynthesis and transport in a SPT-dependent manner.[@cit0014] In this study, we demonstrate that auxin increases cytokinin signaling in the ovary, also in a SPT-dependent manner. However, it is still unclear how auxin signaling interacts with SPT, which we are investigating at the moment. Furthermore, *vice versa*, we have observed that increased cytokinin potentiates auxin signaling activity in the ovary (i.e., cytokinin applications lead to increased activity of the DR5 reporter ([Fig. 2J](#f0002){ref-type="fig"})), forming a robust circuit ([Fig. 3](#f0003){ref-type="fig"}). Figure 3.Models of the regulatory network in early gynoecium development integrating SPT, cytokinin signaling, and auxin signaling, and their synergistic interaction. (A) Previously published model of the regulatory network active in the ovary region in the young gynoecium.[@cit0014] The transcription factor SPT enables cytokinin signaling at the medial region in part by transcriptionally activating the type-B *ARR1* transcription factor. The protein becomes active upon phosphorylation by a phosphorelay cascade initiated when cytokinin is present. Subsequently, both SPT and ARR1 transcriptionally activate the auxin biosynthesis gene *TAA1* and the auxin transporter *PIN3*, probably resulting in an auxin flux. SPT most likely also affects other components of the cytokinin signaling pathway. In the lateral domain, the cytokinin signaling repressor AHP6 restricts cytokinin signaling to the medial domain. (B) Model of the synergistic relationship between auxin and cytokinin signaling in the ovary region of the gynoecium. Auxin positively affects cytokinin signaling in a SPT-dependent manner, and cytokinin positively affects auxin production, thereby positively affecting auxin signaling.

In summary, all these results indicate a synergistic relationship between the two hormones in the ovary region of the young gynoecium, and support the notion that *SPT* plays an important role in this synergistic relationship.
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